כלל ביוטכנו Stock: price and insider trades · Israel
כלל ביוטכנו: what insiders have been doing
Every trade that managers of כלל ביוטכנו disclose to TASE (ISA) is tracked on this page. In the past year (18 October 2025 to 18 October 2026), 4 filings came from 4 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
With 4 filings in twelve months, the company is quieter than the median of 14 filings across the 530 companies we follow on the same exchange.
Over the last twelve months, not one insider purchase of כלל ביוטכנו stock was filed.
Source: insider filings from TASE (ISA). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
- 76,050,880 sharesShareXTAETASE:1447:39:1104280:2015-07-31
- 24,925,078 shares100.0% of flowShareXTAETASE:1447:7729:1104280:2017-03-29
- 4,410,349 sharesShareXTAETASE:1447:7850:1122159:2021-06-21
- 9,894,855 shares100.0% of flowShareXTAETASE:1447:13892:1104280:2026-03-31
4 of 4 declarations
About כלל ביוטכנו
Clal Biotech is a company listed on the XTAE, specializing in the biotechnology sector. It focuses on developing innovative solutions in the healthcare field.